audience statistics Geert Vanden Bossche

VSS Scientific Updates During Pandemic Times #53 : «No one really wants to talk about COVID anymore»From Geert: The WHO have no clue

VSS Scientific Updates During Pandemic Times #47 : Wednesday's 31,444 new local COVID-19 infections broke a record set on April 13, when the

VSS Scientific Updates During Pandemic Times #46 : California Hospitals Treating Patients in Tents as the Number of Positive Flu Tests is Up

VSS Scientific Updates During Pandemic Times #45 : U.S. Flu Hospitalizations Highest in 10 years, Officials Say “An early fall spike in in

Although I do acknowledge the current surge in RSV cases, I don’t think it’s a critical priority. I’ve written several contributions on othe

VSS Scientific Updates During Pandemic Times #42 : The Next U.S. COVID Wave is Coming.Why it Will be 'much weirder than before

VSS Scientific Updates During Pandemic Times #41 : 1. It is 5 past 12! An Urgent Message from Geert Vanden Bossche “…this is my last video m

Bivalent mRNA booster candidates have been developed as a next step in the development of C-19 vaccines to combat the virus; these new vacc

VSS Scientific Updates During Pandemic Times #33 : Bombshell Study: Vaccinated 5X More Contagious Than the Unvaccinated 10 Days After SAR

Bivalent mRNA booster candidates[1] have been developed as a next step in the development of C-19 vaccines to combat the virus; these new vaccines target the induction of a broader immune response than the original vaccines and have to some extent already been approved by regulatory authorities (e.g., FDA, MHRA). One wonders though why studies conducted to test these new vaccines have only enrolled baseline seronegative participants whereas the new vaccines will predominantly be administered to people who have already been vaccinated with first generation C-19 vaccines. This is quite striking as usage of these updated C-19 vaccines to fight dominantly circulating Omicron variants in previously C-19-vaccinated populations is highly contra-indicated as it violates all basic principles of vaccinology. The latter dictate that infection-enhancing antibodies (IEABs), which are directed at a conserved antigenic site comprised within spike protein (S), will be rapidly re-stimulated by the Omicron-adapted S-based vaccine.…

MIS-C is a disease that may occur in school-age children two to six weeks after infection with SARS-CoV-2 (SC-2) virus. MIS-C is a post-infe

VSS Scientific Updates During Pandemic Times #32 : Is COVID Prematurely Aging our Immune Systems? “The concern is that people will be less a

VSS Scientific Updates During Pandemic Times #31 : Elevated Risk of Infection with SARS-CoV-2 Beta, Gamma, and Delta Variant Compared to

Vaccination of vulnerable groups against monkeypox virus (MPV) in a highly C-19 vaccinated population will drive adaptive evolution of MPV a

This is disgusting. As someone who has dedicated 3 decades of his professional life to analyzing the shortcomings of our traditional vaccin